Results 151 to 160 of about 1,512,902 (358)

Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases [PDF]

open access: gold, 2023
Jiawei Guo   +15 more
openalex   +1 more source

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

open access: yesMolecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath   +13 more
wiley   +1 more source

Nanomedicine for the Treatment of Non-Hodgkin Lymphoma [PDF]

open access: yes, 2019
Non-Hodgkin lymphoma, or NHL, is the predominant category of lymphoma. NHL is a type of lymphoid hematopoietic malignancy which approximately 70,000 Americans are diagnosed with annually, with the number of diagnoses growing annually.
Gandhi, B.Pharm, Tanvi
core   +1 more source

Ancient drugs, modern targets

open access: yesCancer Biology & Therapy, 2009
Commentary to:Triptolide: An inhibitor of a disintegrin and metalloproteinase 10 (ADAM10) in cancer cellsRamani Soundararajan, Ria Sayat, George S.
openaire   +2 more sources

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

open access: yesMolecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy   +9 more
wiley   +1 more source

Transformable self-delivered supramolecular nanomaterials combined with anti-PD-1 antibodies alleviate tumor immunosuppression to treat breast cancer with bone metastasis

open access: yesJournal of Nanobiotechnology
Breast cancer is the most common malignant tumor that threatens women’s life and health, and metastasis often occurs in the advanced stage of breast cancer, leading to pathological bone destruction and seriously reducing patient quality of life.
Xueying Liu   +8 more
doaj   +1 more source

Intelligent deep learning model for targeted cancer drug delivery [PDF]

open access: gold
Islam R. Kamal   +3 more
openalex   +1 more source

Gold Nanoplates as Cancer-Targeted Photothermal Actuators for Drug Delivery and Triggered Release [PDF]

open access: hybrid, 2016
Tyler Brann   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy